437 related articles for article (PubMed ID: 15119110)
21. ACOG Committee Opinion #296: first-trimester screening for fetal aneuploidy.
Obstet Gynecol; 2004 Jul; 104(1):215-7. PubMed ID: 15229041
[TBL] [Abstract][Full Text] [Related]
22. Sequential pathways of testing after first-trimester screening for trisomy 21.
Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
[TBL] [Abstract][Full Text] [Related]
23. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
Weisz B; Rodeck CH
Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
[TBL] [Abstract][Full Text] [Related]
24. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
Hu YL;
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
[TBL] [Abstract][Full Text] [Related]
25. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
[TBL] [Abstract][Full Text] [Related]
26. Combining first and second trimester markers for Down syndrome screening: think twice.
Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
[TBL] [Abstract][Full Text] [Related]
27. Sequential pathways of testing after first-trimester screening for trisomy 21.
Malone FD
Obstet Gynecol; 2005 Feb; 105(2):438; author reply 438-9. PubMed ID: 15684179
[No Abstract] [Full Text] [Related]
28. First trimester Down syndrome screening: public health implications.
Fuchs KM; Peipert JF
Semin Perinatol; 2005 Aug; 29(4):267-71. PubMed ID: 16104680
[TBL] [Abstract][Full Text] [Related]
29. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
[TBL] [Abstract][Full Text] [Related]
30. [Screening for Down syndrome and congenital abnormalities in the first versus the second trimester].
Lundsteen C; Brøndum-Nielsen K; Rasmussen K; Petersen GB; Jensen PK
Ugeskr Laeger; 2000 Mar; 162(11):1580-2. PubMed ID: 10868125
[No Abstract] [Full Text] [Related]
31. Integrated serum screening for Down syndrome in primary obstetric practice.
Knight GJ; Palomaki GE; Neveux LM; Smith DE; Kloza EM; Pulkkinen AJ; Williams J; Haddow JE
Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
[TBL] [Abstract][Full Text] [Related]
32. Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing.
Odibo AO; Ghidini A
Prenat Diagn; 2014 Jun; 34(6):511-7. PubMed ID: 24436177
[TBL] [Abstract][Full Text] [Related]
33. Down syndrome screening in twins.
Bush MC; Malone FD
Clin Perinatol; 2005 Jun; 32(2):373-86, vi. PubMed ID: 15922788
[TBL] [Abstract][Full Text] [Related]
34. First-trimester screening for Down's syndrome.
Wald NJ
N Engl J Med; 2004 Feb; 350(6):619-21; author reply 619-21. PubMed ID: 14762194
[No Abstract] [Full Text] [Related]
35. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop.
Reddy UM; Mennuti MT
Obstet Gynecol; 2006 Jan; 107(1):167-73. PubMed ID: 16394055
[TBL] [Abstract][Full Text] [Related]
36. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
Skotko B
Obstet Gynecol; 2006 May; 107(5):1170. PubMed ID: 16648429
[No Abstract] [Full Text] [Related]
37. Prenatal diagnosis now and in the future, in a genetic perspective.
Wahlström J
Acta Obstet Gynecol Scand; 2000 Nov; 79(11):925-7. PubMed ID: 11081672
[No Abstract] [Full Text] [Related]
38. [Prenatal genetic screening: biochemical markers of the first and second quarter].
Grether González P; Aguinaga Ríos M;
Ginecol Obstet Mex; 2009 Feb; 77(2):S27-46. PubMed ID: 19365955
[No Abstract] [Full Text] [Related]
39. [Systematic proposal and obligation of information in Down syndrome screening].
Grangé G; Azria E
J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):535-7. PubMed ID: 18760548
[No Abstract] [Full Text] [Related]
40. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy.
Wallace EM
Br J Obstet Gynaecol; 1996 Nov; 103(11):1174-5. PubMed ID: 8917015
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
